The latest research from Fore Pharma, Global Alzheimer’s Disease Market and Competitive Landscape – 2020, provides comprehensive insights into Alzheimer’s Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Alzheimer’s Disease market size and drug sales. It also provides insights into Alzheimer’s Disease epidemiology and late stage pipeline.
This research covers the following – Alzheimer’s Disease treatment options, Alzheimer’s Disease late stage clinical trials pipeline, Alzheimer’s Disease prevalence by countries, Alzheimer’s Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).
Research Scope:
– Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
– Alzheimer’s Disease pipeline: Find out drugs in clinical trials for Alzheimer’s Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Alzheimer’s Disease epidemiology: Find out number of patients diagnosed (prevalence) with Alzheimer’s Disease by countries
– Alzheimer’s Disease drugs: Identify key drugs marketed and prescribed for Alzheimer’s Disease by countries, including trade name, molecule name, and company
– Alzheimer’s Disease drugs sales: Find out the sales value for Alzheimer’s Disease drugs by countries
– Alzheimer’s Disease market valuations: Find out the market size for Alzheimer’s Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Alzheimer’s Disease drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Alzheimer’s Disease drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Alzheimer’s Disease market
– Develop in-depth knowledge of competition and markets
– Analyze Alzheimer’s Disease drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Alzheimer’s Disease market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Alzheimer’s Disease Treatment Options
2. Alzheimer’s Disease Pipeline Insights
2.1. Alzheimer’s Disease Phase 3 Clinical Trials
2.2. Alzheimer’s Disease Phase 2 Clinical Trials
2.3. Alzheimer’s Disease Phase 1 Clinical Trials
3. Alzheimer’s Disease Epidemiology Analysis by Countries
4. US Alzheimer’s Disease Market Insights
4.1. Marketed Drugs for Alzheimer’s Disease in US
4.2. US Alzheimer’s Disease Market Size & Forecast
4.3. US Alzheimer’s Disease Drugs Sales & Forecast
4.4. US Alzheimer’s Disease Market Share Analysis
5. Germany Alzheimer’s Disease Market Insights
5.1. Marketed Drugs for Alzheimer’s Disease in Germany
5.2. Germany Alzheimer’s Disease Market Size & Forecast
5.3. Germany Alzheimer’s Disease Drugs Sales Forecast
5.4. Germany Alzheimer’s Disease Market Share Analysis
6. France Alzheimer’s Disease Market Insights
6.1. Marketed Drugs for Alzheimer’s Disease in France
6.2. France Alzheimer’s Disease Market Size & Forecast
6.3. France Alzheimer’s Disease Product Sales Forecast
6.4. France Alzheimer’s Disease Market Share Analysis
7. Italy Alzheimer’s Disease Market Insights
7.1. Marketed Drugs for Alzheimer’s Disease in Italy
7.2. Italy Alzheimer’s Disease Market Size & Forecast
7.3. Italy Alzheimer’s Disease Product Sales Forecast
7.4. Italy Alzheimer’s Disease Market Share Analysis
8. Spain Alzheimer’s Disease Market Insights
8.1. Marketed Drugs for Alzheimer’s Disease in Spain
8.2. Spain Alzheimer’s Disease Market Size & Forecast
8.3. Spain Alzheimer’s Disease Product Sales Forecast
8.4. Spain Alzheimer’s Disease Market Share Analysis
9. UK Alzheimer’s Disease Market Insights
9.1. Marketed Drugs for Alzheimer’s Disease in UK
9.2. UK Alzheimer’s Disease Market Size & Forecast
9.3. UK Alzheimer’s Disease Product Sales Forecast
9.4. UK Alzheimer’s Disease Market Share Analysis
10. Europe Alzheimer’s Disease Market Insights
10.1. Europe Alzheimer’s Disease Market Size & Forecast
10.2. Europe Alzheimer’s Disease Product Sales Forecast
10.3. Europe Alzheimer’s Disease Market Share Analysis
11. Japan Alzheimer’s Disease Market Insights
11.1. Marketed Drugs for Alzheimer’s Disease in Japan
11.2. Japan Alzheimer’s Disease Market Size & Forecast
11.3. Japan Alzheimer’s Disease Product Sales Forecast
11.4. Japan Alzheimer’s Disease Market Share Analysis
12. Global Alzheimer’s Disease Market Insights
12.1. Global Alzheimer’s Disease Market Size & Forecast
12.2. Global Alzheimer’s Disease Product Sales Forecast
12.3. Global Alzheimer’s Disease Market Share Analysis
13. Research Methodology
List of Tables
1: Alzheimer’s Disease Phase 3 Clinical Trials, Global, 2020
2: Alzheimer’s Disease Phase 2 Clinical Trials, Global, 2020
3: Alzheimer’s Disease Phase 1 Clinical Trials, Global, 2020
4: Alzheimer’s Disease Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Alzheimer’s Disease in US, 2019
6: US Alzheimer’s Disease Market Size & Forecast ($mn), 2016 – 2025
7: US Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
8: US Alzheimer’s Disease Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Alzheimer’s Disease in Germany, 2019
10: Germany Alzheimer’s Disease Market Size & Forecast ($mn), 2016 – 2025
11: Germany Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
12: Germany Alzheimer’s Disease Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Alzheimer’s Disease in France, 2019
14: France Alzheimer’s Disease Market Size & Forecast ($mn), 2016 – 2025
15: France Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
16: France Alzheimer’s Disease Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Alzheimer’s Disease in Italy, 2019
18: Italy Alzheimer’s Disease Market Size & Forecast ($mn), 2016 – 2025
19: Italy Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
20: Italy Alzheimer’s Disease Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Alzheimer’s Disease in Spain, 2019
22: Spain Alzheimer’s Disease Market Size & Forecast ($mn), 2016 – 2025
23: Spain Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
24: Spain Alzheimer’s Disease Market Events and Trends, 2016 – 2025
25: Marketed Drugs for Alzheimer’s Disease in UK, 2019
26: UK Alzheimer’s Disease Market Size & Forecast ($mn), 2016 – 2025
27: UK Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
28: UK Alzheimer’s Disease Market Events and Trends, 2016 – 2025
29: Europe Alzheimer’s Disease Market Size & Forecast ($mn), 2016 – 2025
30: Europe Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
31: Marketed Drugs for Alzheimer’s Disease in Japan, 2019
32: Japan Alzheimer’s Disease Market Size & Forecast ($mn), 2016 – 2025
33: Japan Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
34: Japan Alzheimer’s Disease Market Events and Trends, 2016 – 2025
35: Global Alzheimer’s Disease Market Size & Forecast ($mn), 2016 – 2025
36: Global Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
List of Figures
1: Alzheimer’s Disease Pipeline by Phase (%), Global, 2020
2: Alzheimer’s Disease Prevalence by Countries, 2016 – 2025
3: US Alzheimer’s Disease Market Size ($mn), 2016 – 2025
4: US Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
5: US Alzheimer’s Disease Market Share by Drugs (%), 2019
6: US Alzheimer’s Disease Market – Future Market Share (%), 2025
7: Germany Alzheimer’s Disease Market Size ($mn), 2016 – 2025
8: Germany Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
9: Germany Alzheimer’s Disease Market Share by Drugs (%), 2019
10: Germany Alzheimer’s Disease Market – Future Market Share (%), 2025
11: France Alzheimer’s Disease Market Size ($mn), 2016 – 2025
12: France Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
13: France Alzheimer’s Disease Market Share by Drugs (%), 2019
14: France Alzheimer’s Disease Market – Future Market Share (%), 2025
15: Italy Alzheimer’s Disease Market Size ($mn), 2016 – 2025
16: Italy Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
17: Italy Alzheimer’s Disease Market Share by Drugs (%), 2019
18: Italy Alzheimer’s Disease Market – Future Market Share (%), 2025
19: Spain Alzheimer’s Disease Market Size ($mn), 2016 – 2025
20: Spain Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
21: Spain Alzheimer’s Disease Market Share by Drugs (%), 2019
22: Spain Alzheimer’s Disease Market – Future Market Share (%), 2025
23: UK Alzheimer’s Disease Market Size ($mn), 2016 – 2025
24: UK Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
25: UK Alzheimer’s Disease Market Share by Drugs (%), 2019
26: UK Alzheimer’s Disease Market – Future Market Share (%), 2025
27: Europe Alzheimer’s Disease Market Size ($mn), 2016 – 2025
28: Europe Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
29: Europe Alzheimer’s Disease Market Share by Drugs (%), 2019
30: Europe Alzheimer’s Disease Market – Future Market Share (%), 2025
31: Japan Alzheimer’s Disease Market Size ($mn), 2016 – 2025
32: Japan Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
33: Japan Alzheimer’s Disease Market Share by Drugs (%), 2019
34: Japan Alzheimer’s Disease Market – Future Market Share (%), 2025
35: Global Alzheimer’s Disease Market Size ($mn), 2016 – 2025
36: Global Alzheimer’s Disease Product Sales ($mn), 2016 – 2025
37: Global Alzheimer’s Disease Market Share by Drugs (%), 2019
38: Global Alzheimer’s Disease Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.